RT
RS Tavares

Emerging

7
Works
6
Citations
1
H-Index
Search Authors
Author Statistics
  • OpenAlex ID A5003967499
  • i10-Index 0
  • 2-Yr Mean Citedness 0.00
External Links
OpenAlex Profile

RS Tavares

Also known as: R.S. Taavares, RS Tavares

7

Total Works

6

Citations

1

H-Index

0

i10-Index

Citation & Works Trend by Year
7 years active
Top Research Topics
Myeloproliferative Neoplasms: Diagnosis and Treatment (4) Acute Myeloid Leukemia Research (3) Chronic Lymphocytic Leukemia Research (2) Hematological disorders and diagnostics (2) Rheumatoid Arthritis Research and Therapies (1)
Recent Publications
7 shown
Year Publication Title Citations Action
2025 IMMUNE MATURATION AND CHECKPOINT DYNAMICS DURING TYROSINE KINASE INHIBITOR DOSE REDUCTION PREDICT RELAPSE RISK IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDERGOING TREATMENT DISCONTINUATION Hematology Transfusion and Cell Therapy 0
2021 IMPACTO FINANCEIRO DE ACALABRUTINIBE COMPARADO COM IBRUTINIBE NO TRATAMENTO DE LINFOMA DE CÉLULAS DO MANTO (LCM) RECIDIVADO OU REFRATÁRIO (RR) NA PERSPECTIVA DO SISTEMA DE SAÚDE SUPLEMENTAR BRASILEIRO Hematology Transfusion and Cell Therapy 0
2021 CLINICAL, CYTOGENETIC AND MOLECULAR CHARACTERIZATION OF BRAZILIAN COHORT PATIENTS WITH PRIMERY MYELOFIBROSIS AND MYELOFIBROSIS POST-POLYCYTTHEMIA VERA AND POST-ESSENTIAL THROMBOCYTHEMIA Hematology Transfusion and Cell Therapy 0
2021 ATUAÇÃO DO FARMACÊUTICO NA EQUIPE MULTIPROFISSIONAL DE SAÚDE – UM RELATO DE CASO DE FALHA TERAPÊUTICA POR POSSÍVEL INTERAÇÃO MEDICAMENTOSA E ARMAZENAMENTO INADEQUADO DO MEDICAMENTO EM UM PACIENTE PORTADOR DE LEUCEMIA MIELOIDE CRÔNICA Hematology Transfusion and Cell Therapy 1
2020 A IMPORTÂNCIA DA APLICAÇÃO DO ESCORES PROGNÓSTICOS DIPPS E DIPPS PLUS E O PAPEL DO CARIÓTIPO NESSA APLICAÇÃO EM UM GRUPO DE PACIENTES BRASILEIROS COM MIELOFIBROSE Hematology Transfusion and Cell Therapy 0
2016 Safety and efficacy of Ruxolitinib in expanded-access JUMP study: an update from a cohort of 1869 patients 0
2015 SAFETY AND EFFICACY OF RUXOLITINIB (RUX) IN PATIENTS WITH INTERMEDIATE-1-RISK MYELOFIBROSIS (MF) FROM AN OPEN-LABEL, MULTICENTER, SINGLE-ARM EXPANDED-ACCESS STUDY Haematologica 5

Data source: OpenAlex API